[Skip to Content]
[Skip to Content Landing]
Medical News & Perspectives
April 3, 2002

Scientists Find Some Genes a Bad Omen for Anti-HIV Drug

Author Affiliations

Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2002American Medical Association

JAMA. 2002;287(13):1637. doi:10.1001/jama.287.13.1637-JMN0403-2-1

Seattle—With the human genome sequence largely in hand, researchers have predicted that pharmacogenetics—the study of the genetic causes of individual variations in the body's response to drugs—will help physicians tailor treatment to patients' genetic makeup, allowing them to prescribe medications most likely to help and least likely to cause harm. Now, researchers have reported here at the Ninth Annual Retrovirus Conference that they can identify HIV-infected individuals with a particular gene variant that indicates they are at risk of experiencing a severe, potentially fatal reaction to the widely used antiretroviral drug abacavir.

First Page Preview View Large
First page PDF preview
First page PDF preview